Search Results 851-860 of 8077 for TNF
The purpose of this study is to evaluate the 12-week progression free survival (PFS) rate in treated subjects, based on historical sarcoma trial outcomes (PFS ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
This expanded access therapeutic protocol aims to allow patients suffering from inoperable, somatostatin receptor positive, neuroendocrine tumors, progressive ...
This content is password protected. To view it please enter your password below: Password: About the News Network · Newsbureau@mayo.edu.
The purpose of this study is to evaluate the real-world utilization of ceftolozane/tazobactam (C/T) and to assess patient outcomes. Participation eligibility.
About this study. The primary objective of this study is to determine the safety and tolerability of utilizing the insulin-like growth factor-1-methotrexate ...
The study will prospectively determine the clinical utility of CMV cell-mediated immunity using the Quantiferon test. The investigators will use the assay ...
The purpose of this study is designed to evaluate the effectiveness and safety of AL101 monotherapy in subjects with Notch-activated recurrent or metastatic ...
The purpose of this study is to evaluate patients who are intolerant of current enteral formula to be transitioned to peptide-based therapy to assess if ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Give by Dec. 3 to double your impact 2X.